Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Bourhis, Jean
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. [electronic resource] - The Lancet. Oncology Feb 2012 - 145-53 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(11)70346-1 doi
Adult
Aged
Carcinoma--therapy
Chemoradiotherapy--methods
Disease-Free Survival
Female
Head and Neck Neoplasms--therapy
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Staging
Patient Safety
Treatment Outcome
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. [electronic resource] - The Lancet. Oncology Feb 2012 - 145-53 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(11)70346-1 doi
Adult
Aged
Carcinoma--therapy
Chemoradiotherapy--methods
Disease-Free Survival
Female
Head and Neck Neoplasms--therapy
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Staging
Patient Safety
Treatment Outcome